FDA Issues New Warning of Cancers Linked to Breast Implants
The U.S. Food and Drug Administration (FDA) issued a safety communication on Sept. 8, 2022 warning that certain cancers may develop in scar tissue “capsules” that form around breast implants. Cancers cited in the report include squamous cell carcinoma and various lymphomas. The malignancies are not exclusive to a certain type of implant and have […]
FDA Reports Systemic Health Problems in Women With Breast Implants
Breast implant surgery is the most common cosmetic surgical procedure in the United States, with more than 313,000 surgeries performed in 2018—a 48 percent increase since 2000.1 Silicone implants are the most common reconstructive breast surgery. In 2018, the American Society of Plastic Surgeons (ASPS) reported 101,657 breast reconstruction procedures, of which 78,814 used silicone […]
